中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2020 Vol. 36, No. 6

Display Method:
Editorial
New thoughts about renaming nonalcoholic fatty liver disease
Gao Xin
2020, 36(6): 1201-1204. DOI: 10.3969/j.issn.1001-5256.2020.06.001
Abstract(1455) PDF (1961KB)(452) Cited By (30)
Abstract:

Nonalcoholic fatty liver disease( NAFLD) is a multisystem disease involving metabolic disorder and is more common in patients with obesity and type 2 diabetes mellitus( T2 DM),with similar adverse outcomes to these two comorbidities. For a long time,NAFLD has emphasized liver lesions and outcomes of...

Discussions by experts
Clinical significance of renaming nonalcoholic fatty liver disease
Ceng Jing, Fan JianGao
2020, 36(6): 1205-1207. DOI: 10.3969/j.issn.1001-5256.2020.06.002
Abstract(1654) PDF (1930KB)(406) Cited By (37)
Abstract:

The terms nonalcoholic steatohepatitis and nonalcoholic fatty liver disease( NAFLD) were first used in the 1980 s to describe a condition of similar liver histological changes to alcoholic liver disease,without excessive drinking nor other factors for liver injury. In-depth research on NAFLD has ach...

Is nonalcoholic fatty liver disease a complication of diabetes?
Bian Hua, Gao Xin
2020, 36(6): 1208-1212. DOI: 10.3969/j.issn.1001-5256.2020.06.003
Abstract(714) PDF (250KB)(140) Cited By (6)
Abstract:

Although nonalcoholic fatty liver disease( NAFLD) is a liver disease,it has attracted more and more attention among endocrinologists. There are complex interactions between the metabolic status of diabetes and the pathology of NAFLD,and they promote the development of each other. In the population w...

Can type 2 diabetes mellitus be reversed by improving nonalcoholic fatty liver disease?
Yan HongMei
2020, 36(6): 1213-1216. DOI: 10.3969/j.issn.1001-5256.2020.06.004
Abstract:

Nonalcoholic fatty liver disease( NAFLD) is associated with a 2-to 3-fold increase in the risk of developing type 2 diabetes( T2 DM) in non-diabetic patients,and therefore,the NAFLD population is considered a large population at a high risk of T2 DM. In the population diagnosed with T2 DM,the preval...

Research advances in the pathogenesis of nonalcoholic fatty liver disease-related hepatocellular carcinoma
Luo Yan, Shi JunPing
2020, 36(6): 1217-1220. DOI: 10.3969/j.issn.1001-5256.2020.06.005
Abstract(1197) PDF (1884KB)(291) Cited By (4)
Abstract:

Nonalcoholic steatohepatitis( NASH)/nonalcoholic fatty liver disease( NAFLD) has gradually become one of the main causes of hepatocellular carcinoma( HCC) in Western developed countries. Different from the typical evolution process of hepatitis,liver cirrhosis,and liver cancer,nearly 40% NAFLD patie...

Application of nuclear receptor in pathogenesis research and drug development for nonalcoholic fatty liver disease
Chen YiYan, Lu Yan
2020, 36(6): 1221-1223. DOI: 10.3969/j.issn.1001-5256.2020.06.006
Abstract(1075) PDF (1872KB)(301) Cited By (4)
Abstract:

Nonalcoholic fatty liver disease( NAFLD) is the most common type of liver disease in developed countries,and in recent years,the prevalence rate of NAFLD tends to increase in China,which brings heavy burden to the social health system. The development and progression of NAFLD are affected by the int...

Guidelines
Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease
Xue Rui, Fan JianGao
2020, 36(6): 1224-1227. DOI: 10.3969/j.issn.1001-5256.2020.06.007
Abstract(2860) PDF (1894KB)(1022) Cited By (270)
Abstract:
Expert consensus on the application of artificial liver blood purification system in the treatment of severe and critical COVID-19
National Clinical Research Center for Infectious DiseasesState Key Laboratory for Diagnosis and Treatment of Infectious Diseases
2020, 36(6): 1228-1229. DOI: 10.3969/j.issn.1001-5256.2020.06.008
Abstract(1157) PDF (1858KB)(204) Cited By (6)
Abstract:

The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease. The artificial liver blood purification system can remove inflammatory factors,alleviate the damage of the i...

An excerpt of clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement
Xu ShiXue, Chen MingKai, Qi XingShun
2020, 36(6): 1230-1233. DOI: 10.3969/j.issn.1001-5256.2020.06.009
Abstract:
An excerpt of liver trauma: WSES 2020 guidelines
Peng Zhao, Wang MingDa, Shen Feng, Yang Tian
2020, 36(6): 1234-1240. DOI: 10.3969/j.issn.1001-5256.2020.06.010
Abstract:
Guideline Interpretation
Interpretation of International consensus statement for endoscopic management of distal biliary stricture( 2019)
Zhu Liang, Chen YouXiang
2020, 36(6): 1241-1244. DOI: 10.3969/j.issn.1001-5256.2020.06.011
Abstract:

Distal biliary stricture is a biliary lesion commonly seen in clinical practice and can be caused by benign and malignant diseases.Although endoscopic technique has become a major treatment method for distal biliary stricture,there is still a lack of comprehensive understanding of this condition. Th...

Viral hepatitis
Drug resistance mutations in polymerase region and related influencing factors in patients with hepatitis B virus infection
Li Sha, Peng HuaBin, Li ShuQin, Zhou Jing, Wang LiPing
2020, 36(6): 1245-1251. DOI: 10.3969/j.issn.1001-5256.2020.06.012
Abstract(1212) PDF (2079KB)(172) Cited By (1)
Abstract:

Objective To investigate the pattern of drug resistance mutations of the genes in the reverse transcriptase( RT) region and its association with clinical features in patients with hepatitis B virus( HBV) infection in Xuzhou,Jiangsu,China,as well as the influencing factors for drug resistance. Method...

Expression features of glucocorticoid receptor and its association with treatment outcome in patients with hepatitis B virus-related acute-on-chronic liver failure
Dong JinLing, Jia Lin, Yang Jun, Yu HongWei, Hu ZhongJie, Zhu YueKe, Meng QingHua
2020, 36(6): 1252-1257. DOI: 10.3969/j.issn.1001-5256.2020.06.013
Abstract:

Objective To investigate the expression features of glucocorticoid receptor( GR) and its subtypes α and β in patients with early-or middle-stage hepatitis B virus-related acute/subacute-on-chronic liver failure( HBV-ACLF) treated by glucocorticoid( GC) and their association with sensitivity to gluco...

Value of the COSSH-ACLFs model in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure
Tian XiaoLi, Wu SongLin, Wang Bo, Wu Gang
2020, 36(6): 1258-1262. DOI: 10.3969/j.issn.1001-5256.2020.06.014
Abstract(1396) PDF (1991KB)(161) Cited By (22)
Abstract:

Objective To investigate the value of the COSSH-ACLFs model in predicting the short-term( 90-day) prognosis of patient with hepatitis B virus-related acute-on-chronic liver failure( HBV-ACLF). Methods A total of 573 patients who were diagnosed with HBV-ACLF in The Affiliated Hospital of Southwest Me...

Efficacy of direct-acting antiviral agents in treatment of chronic hepatitis C and its effect on liver stiffness and aspartate aminotransferase-to-platelet ratio index
Liang Jing, Zhang YaPing, Liu Fang, Xiang HuiLing, Lu: HongMin, Han Tao
2020, 36(6): 1263-1267. DOI: 10.3969/j.issn.1001-5256.2020.06.015
Abstract(1243) PDF (2062KB)(167) Cited By (12)
Abstract:

Objective To investigate the real-world viral response of chronic hepatitis C( CHC) patients receiving direct-acting antiviral agent( DAA) treatment and its effect on liver stiffness measurement( LSM) and aspartate aminotransferase-to-platelet ratio index( APRI). Methods The CHC patients who were co...

Liver fibrosis and liver cirrhosis
Value of transient elastography in the diagnosis of liver fibrosis in chronic hepatitis B children of different ages
Xu ZhiQiang, Dong Yi, Wang FuChuan, Wang LiMin, Yan JianGuo, Cao LiLi, Wang Pu, Li AiQin, Zhong YanWei, Zhang Min
2020, 36(6): 1268-1272. DOI: 10.3969/j.issn.1001-5256.2020.06.016
Abstract(1212) PDF (2619KB)(176) Cited By (20)
Abstract:

Objective To investigate the value of transient elastography( FibroScan) in the diagnosis of liver fibrosis in chronic hepatitis B( CHB) children of different ages. Methods A total of 280 CHB children,aged < 18 years,who were hospitalized in The Fifth Medical Center of Chinese PLA General Hospita...

Clinical effect of terlipressin combined with somatostatin in treatment of esophagogastric variceal bleeding with liver cirrhosis
Li XiaoLu, Ding HuiGuo, Ceng AJuan, Lu: XinYue, Li Lei
2020, 36(6): 1273-1277. DOI: 10.3969/j.issn.1001-5256.2020.06.017
Abstract(1396) PDF (2642KB)(213) Cited By (18)
Abstract:

Objective To investigate the clinical effect of terlipressin combined with somatostatin in the treatment of esophagogastric variceal bleeding( EVB) in patients with liver cirrhosis. Methods A retrospective analysis was performed for the clinical data of 73 patients with liver cirrhosis and EVB who w...

Value of Child-Pugh score,Model for End-Stage Liver Disease score,MELD combined with serum sodium concentration,APASAL score,and R-score in predicting rebleeding and death in cirrhotic patients with esophagogastric variceal bleeding
Ma JiaLi, Chen Xu, He LingLing, Wei HongShan, Li Ping
2020, 36(6): 1278-1283. DOI: 10.3969/j.issn.1001-5256.2020.06.018
Abstract(1932) PDF (2051KB)(275) Cited By (34)
Abstract:

Objective To investigate the value of Child-Pugh score,Model for End-Stage Liver Disease( MELD) score,MELD combined with serum sodium concentration( MELD-Na score),APASAL score,and R-score in predicting rebleeding and death in cirrhotic patients with esophagogastric variceal bleeding. Methods The pa...

Liver neoplasms
Value of the NDRG family in the diagnosis and prognostic evaluation of hepatocellular carcinoma
Luo Qiong, Wang ChunMing, Liao HangYu, Chen KunLing, Pan MingXin
2020, 36(6): 1284-1288. DOI: 10.3969/j.issn.1001-5256.2020.06.019
Abstract:

Objective To investigate the expression of the N-myc downstream regulated gene( NDRG) family in hepatocellular carcinoma( HCC) and its association with pathological features and prognosis based on bioinformatics mining. Methods The expression of the NDRG family and the survival data of patients with...

Effect of extracellular ubiquitin on the proliferation,invasion,and migration of hepatoma cells
Zhang Yang, Chen ShuYing, Xu GuangRu
2020, 36(6): 1289-1292. DOI: 10.3969/j.issn.1001-5256.2020.06.020
Abstract:

Objective To investigate the effect of extracellular ubiquitin on the proliferation,invasion,and migration of hepatoma cells by in vitro cell experiments. Methods The hepatoma cells( HepG2) were treated with extracellular ubiquitin at different concentrations( 200,400,and 800 ng/ml); CCK-8 assay was...

Value of a logistic regression model based on the clinical features of liver cancer in judging the traditional Chinese medicine syndrome types of primary liver cancer
Lin DongYi, Peng Bo, Zheng JingHui, Wang ZongYu, Li HanZhong, He JianBo, Li KeZhi, Wu GuoBin, Chen Chuang
2020, 36(6): 1293-1298. DOI: 10.3969/j.issn.1001-5256.2020.06.021
Abstract(1114) PDF (2102KB)(162) Cited By (19)
Abstract:

Objective To investigate the association of the clinical features of liver cancer patients,including albumin-bilirubin( ALBI)and neutrophil-lymphocyte ratio( NLR),with the traditional Chinese medicine( TCM) syndrome types of primary liver cancer,and to establish a clinical judgment model for TCM syn...

Other liver diseases
Association between nonalcoholic fatty liver disease and colorectal adenomatous polyps
Chuan LiXue, Chang Jiang, Zhao JinHan, Li LuoHua, Yang XuYao, Yu Di
2020, 36(6): 1299-1303. DOI: 10.3969/j.issn.1001-5256.2020.06.022
Abstract(1036) PDF (1909KB)(175) Cited By (15)
Abstract:

Objective To investigate the association between nonalcoholic fatty liver disease( NAFLD) and colorectal adenomatous polyps and the correlation of NAFLD severity with the risk of colorectal adenomatous polyps. Methods A total of 67 patients with colorectal adenomatous polyps who were hospitalized in...

Association between nonalcoholic fatty liver disease and epicardial adipose tissue: A Meta-analysis
Wang XiangHong, Ma BaoHua, Zou XiuLan, Yao KeCheng, He Qian
2020, 36(6): 1304-1309. DOI: 10.3969/j.issn.1001-5256.2020.06.023
Abstract(1098) PDF (3036KB)(190) Cited By (1)
Abstract:

Objective To investigate the association between nonalcoholic fatty liver disease( NAFLD) and epicardial adipose tissue( EAT). Methods Databases including PubMed,Embase,Web of Science,Wanfang Data,and CNKI were searched for the articles on the association of thickness and volume of EAT with NAFLD pu...

Metabolic characteristics of nonalcoholic fatty liver disease and related risk factors in non-obese population
Tian Tian, Hu WenWei, Li Xue, Li Ji, Zhang Dan, Li ZhangZheng
2020, 36(6): 1310-1313. DOI: 10.3969/j.issn.1001-5256.2020.06.024
Abstract(1181) PDF (1888KB)(204) Cited By (9)
Abstract:

Objective To investigate the metabolic characteristics of nonalcoholic fatty liver disease( NAFLD) and related risk factors in non-obese population. Methods A retrospective analysis were performed for 12 125 individuals who underwent physical examination in Physical Examination Center of PLA Rocket ...

Influence of the interaction between abdominal obesity and hypertriglyceridemia on the development of nonalcoholic fatty liver disease
Cui HaoZhe, Ma XiangMing, Liu Qian, Sun MiaoMiao, Zhao Li, Wang WanChao, Liu SiQing, Cao LiYing
2020, 36(6): 1314-1319. DOI: 10.3969/j.issn.1001-5256.2020.06.025
Abstract(1175) PDF (1984KB)(216) Cited By (13)
Abstract:

Objective To investigate whether abdominal obesity and hypertriglyceridemia have a synergistic effect on the development of nonalcoholic fatty liver disease( NAFLD). Methods A prospective cohort study was conducted. Physical examination data were collected from 70 776 on-the-job or retired employees...

Association between liver fibrosis and serum uric acid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
Liu Ting, Wang ChenTing, Liu MeiXiao, Liu JianFeng, Zheng ShaoXiong
2020, 36(6): 1320-1324. DOI: 10.3969/j.issn.1001-5256.2020.06.026
Abstract(1266) PDF (2132KB)(187) Cited By (18)
Abstract:

Objective To investigate the association between liver fibrosis and serum uric acid in patients with type 2 diabetes mellitus( T2 DM) and nonalcoholic fatty liver disease( NAFLD). Methods A total of 328 patients with T2 DM and NAFLD who attended Cangzhou People's Hospital from January 2018 to August...

Association between microRNA-155/SH2-containing inositol phosphatase-1 and cardiovascular events in patients with nonalcoholic fatty liver disease
Wang Fan, Sun Wu, Ma YuLin, Jiang HongJun
2020, 36(6): 1325-1329. DOI: 10.3969/j.issn.1001-5256.2020.06.027
Abstract(1058) PDF (1950KB)(149) Cited By (3)
Abstract:

Objective To investigate the association between microRNA-155( miR-155)/SH2-containing inositol phosphatase-1( SHIP-1) and cardiovascular events in patients with nonalcoholic fatty liver disease( NAFLD). Methods A total of 104 patients with NAFLD who were admitted to our hospital from March 2018 to ...

Clinical effect and safety of magnesium isoglycyrrhizinate in treatment of autoimmune-like drug-induced liver injury
Du XiaoFei, Chen Jie, Huang ChunYang, Zhang XiaoDan, Liu Dan, Bian XinQu, Han Ying, Liu YanMin, Dan Jing
2020, 36(6): 1330-1333. DOI: 10.3969/j.issn.1001-5256.2020.06.028
Abstract(1582) PDF (1895KB)(213) Cited By (15)
Abstract:

Objective To investigate the clinical effect and safety of magnesium isoglycyrrhizinate in the treatment of autoimmune-like drug-induced liver injury. Methods A total of 53 patients with autoimmune-like drug-induced liver injury who were hospitalized in Beijing YouAn Hospital,Capital Medical Univers...

Expression and significance of semaphorin 3A and its receptor NRP-1 in a rat model of chronic hepatic encephalopathy
Ruan JingSheng, Chen Chuang, Li KeZhi, Huang Shan, He JianBo, Ceng AiPing, Lian Fang, Wu GuoBin
2020, 36(6): 1334-1341. DOI: 10.3969/j.issn.1001-5256.2020.06.029
Abstract(1010) PDF (3207KB)(182) Cited By (2)
Abstract:

Objective To investigate the changes in the expression of semaphorin 3 A( Sema3 A) and receptor neuropilins-1( NRP-1) in the prefrontal cortex and the hippocampal CA1,CA3,and DG regions in rats with hepatic encephalopathy( HE) and their possible significance. Methods A total of 40 Sprague-Dawley rat...

Pancreatic disease
Value of early admission scoring systems in predicting the severity and prognosis of acute pancreatitis
An WenHui, He XuChang, Yang Jing, Ren BeiBei, Zhang Xue, Leng Jiao, Luo Run
2020, 36(6): 1342-1346. DOI: 10.3969/j.issn.1001-5256.2020.06.030
Abstract(1179) PDF (2111KB)(193) Cited By (25)
Abstract:

Objective To screen out the scoring system with the highest predictive value by analyzing the comprehensive scoring systems which can assess the severity and prognosis of acute pancreatitis in the early stage( within 24 hours) after admission. Methods A retrospective analysis was performed for the c...

Case reports
Clinical cure in patients with hepatitis B cirrhosis treated with pegylated interferon α-2b: A case report
Gao XiaoHong, Cheng Ni, Cao JiaoJiao
2020, 36(6): 1347-1348. DOI: 10.3969/j.issn.1001-5256.2020.06.031
Abstract(1258) PDF (2071KB)(168) Cited By (4)
Abstract:
A case of recurrent hilar cholangiocarcinoma in the elderly treated with anlotinib
Cheng Si, Chen Bao, Xu Nie
2020, 36(6): 1349-1350. DOI: 10.3969/j.issn.1001-5256.2020.06.032
Abstract(1131) PDF (1945KB)(124) Cited By (2)
Abstract:
A case of atypical hepatic lymphoid hyperplasia with Sjogren’s syndrome
Yang Xiao, Zhou Xiao, Mu XiaoXin, Wu JinDao, Hu ChunYang, Kong LianBao
2020, 36(6): 1351-1353. DOI: 10.3969/j.issn.1001-5256.2020.06.033
Abstract:
Liver subcapsular biliary cyst successfully treated by endoscopic retrograde cholangiopancreatography: A case report
Hua HaiYang, Li JianHui, Su Bin, Xuan XiaoYu
2020, 36(6): 1354-1355. DOI: 10.3969/j.issn.1001-5256.2020.06.034
Abstract:
A case of splenic rupture after endoscopic retrograde cholangiopancreatography
Wang AiMin, Jiao HaiTao, Fang ChaoRan, Li JianHui
2020, 36(6): 1356-1357. DOI: 10.3969/j.issn.1001-5256.2020.06.035
Abstract:
Reviews
Research advances in predictive markers for HBeAg seroconversion in chronic hepatitis B patients treated with nucleos( t) ide analogues
Jiang YingYing, Zheng SuJun
2020, 36(6): 1358-1361. DOI: 10.3969/j.issn.1001-5256.2020.06.036
Abstract(828) PDF (224KB)(112) Cited By (5)
Abstract:

Nucleos( t) ide analogues( NAs) are effective inhibitors for HBV replication and have become the preferred antiviral regimen for most patients with chronic hepatitis B( CHB). HBeAg seroconversion is an important index used to evaluate the durability and efficacy of antiviral therapy in HBeAg-positiv...

Clinical application of transient elastography in liver cirrhosis and its complications
Liu LinXiang, Nie Yuan, Zhu Xuan
2020, 36(6): 1362-1365. DOI: 10.3969/j.issn.1001-5256.2020.06.037
Abstract(1020) PDF (1892KB)(168) Cited By (14)
Abstract:

Liver cirrhosis is a pathological stage in which most chronic liver diseases progress to the advanced stages,and the main complications of liver cirrhosis include portal hypertension,gastroesophageal variceal bleeding,and liver cancer. Transient elastography( TE) uses acoustic waves to obtain liver ...

Advances in the application of magnetic resonance imaging in hepatic fat quantification in patients with nonalcoholic fatty liver disease
Mu Rong, Lu LunGen
2020, 36(6): 1366-1369. DOI: 10.3969/j.issn.1001-5256.2020.06.038
Abstract(1120) PDF (1887KB)(217) Cited By (14)
Abstract:

Hepatic fat content is an important index for the early diagnosis,disease grading,and outcome evaluation of nonalcoholic fatty liver disease( NAFLD). Various magnetic resonance imaging( MRI) methods have been used to determine hepatic fat content in NAFLD,among which proton density fat fraction obta...

Epidemiology of nonalcoholic fatty liver disease in some regions of China
Wu TingFeng, Liao XianHua, Zhong BiHui
2020, 36(6): 1370-1373. DOI: 10.3969/j.issn.1001-5256.2020.06.039
Abstract(2813) PDF (1893KB)(548) Cited By (145)
Abstract:

Nonalcoholic fatty liver disease( NAFLD) has replaced viral hepatitis and become the most important chronic liver disease in the world. Abdominal ultrasound remains the main method for the diagnosis of NAFLD in China. The studies in China showed that in the last two decades,the prevalence rate of NA...

Role of bile acid metabolism and related receptors in the development and progression of nonalcoholic fatty liver disease
Zhang Yang, Li JunXiang, Wang YunLiang
2020, 36(6): 1374-1377. DOI: 10.3969/j.issn.1001-5256.2020.06.040
Abstract(967) PDF (1897KB)(158) Cited By (11)
Abstract:

Enterohepatic circulation plays an important role in the pathogenesis of nonalcoholic fatty liver disease( NAFLD). Bile acid is the basic substance of enterohepatic circulation and plays an important role in lipid metabolism,intestinal flora regulation,and host immunity. This article summarizes the ...

Research advances in the role of intestinal flora regulation in the traditional Chinese and Western medicine therapy for nonalcoholic fatty liver disease
Xu Meng, Sun FengXia, Li Jie, Li XiaoLing
2020, 36(6): 1378-1381. DOI: 10.3969/j.issn.1001-5256.2020.06.041
Abstract(1077) PDF (2050KB)(167) Cited By (7)
Abstract:

Recent studies have shown that intestinal flora can play a role in the treatment of nonalcoholic fatty liver disease( NAFLD),and intestinal flora regulation can provide new thoughts for the treatment of NAFLD. This article reviews the research advances in the role of intestinal flora regulation in t...

Association of visfatin with thyroid dysfunction in patients with nonalcoholic fatty liver disease
Ren ShiPing, Ma ZhenQi, Wang XueHong
2020, 36(6): 1382-1385. DOI: 10.3969/j.issn.1001-5256.2020.06.042
Abstract:

Recent studies have found that visfatin is involved in lipid metabolism in patients with nonalcoholic fatty liver disease( NAFLD),and about 25% of NAFLD patients have thyroid dysfunction. It has also been found that visfatin is involved in autoimmune regulation through the autocrine or paracrine pat...

Advances in immune checkpoint inhibitor combined with other treatment methods for hepatocellular carcinoma
Sun Tao, Ren YanQiao, Cao YanYan, Zheng ChuanSheng
2020, 36(6): 1386-1388. DOI: 10.3969/j.issn.1001-5256.2020.06.043
Abstract(1119) PDF (1883KB)(154) Cited By (10)
Abstract:

In recent years,immune checkpoint inhibitor( ICI) in the treatment of unresectable liver cancer has attracted great attention in China and foreign countries and great progress has been achieved,but ICI monotherapy cannot bring benefits to most patients with liver cancer. Therefore,it is a new trend ...

Predictive factors for the clinical effect of PD-1/PD-L1 checkpoint inhibitors in treatment of hepatocellular carcinoma
Ha FuShuang, Han Tao, Tang Fei, Yan JunQing, Wang HaoYu
2020, 36(6): 1389-1392. DOI: 10.3969/j.issn.1001-5256.2020.06.044
Abstract:

At present,there is still a lack of uniform treatment strategies for hepatocellular carcinoma( HCC). Immunotherapy,especially PD-1/PD-L1 checkpoint inhibitors,is a novel therapy for HCC and can bring survival benefits to patients with advanced HCC. However,research data show that only a small number...

Hepatic macrophage-targeted therapy for fatty liver disease: Opportunities and challenges
Niu ChunYan, Zhao XiangYang
2020, 36(6): 1393-1397. DOI: 10.3969/j.issn.1001-5256.2020.06.045
Abstract:

Hepatic macrophages are an important cell component in the natural immune system. In the physiological environment,they can recognize and eliminate necrotic or apoptotic cell fragments,pathogens,and presenting antigens and participate in adaptive immunity and immune surveillance,while in the patholo...

Research advances in primary biliary cholangitis with extrahepatic autoimmune diseases
Tu RongFang, Yang Xue, Tang YingMei
2020, 36(6): 1398-1401. DOI: 10.3969/j.issn.1001-5256.2020.06.046
Abstract(935) PDF (1886KB)(198) Cited By (10)
Abstract:

Primary biliary cholangitis( PBC) is a chronic autoimmune liver disease characterized by progressive destruction of the small intrahepatic bile ducts. Patients with PBC often have extrahepatic autoimmune diseases,which can involve multiple organs and systems including the gastrointestinal tract,lung...

Current status of the research on liver injury caused by SARS-CoV-2
Zhou YaNing, Feng Gong, Liu ManLing, Yan QinQin, Fan LiPing, Mi Man
2020, 36(6): 1402-1406. DOI: 10.3969/j.issn.1001-5256.2020.06.047
Abstract:

The outbreak of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2( SARS-CoV-2) in Wuhan,China poses a major threat to public health. SARS-CoV-2 is highly homologous to severe acute respiratory syndrome-associated coronavirus and Middle East respiratory syndrome-associated cor...

Research advances in the clinical features of liver disease during pregnancy
Duan XingPing, Wang Yan, Huang ChangYou, Zheng HuiXian, Luo Yi, Tan ZhengWen, Ren Yu
2020, 36(6): 1407-1411. DOI: 10.3969/j.issn.1001-5256.2020.06.048
Abstract(1013) PDF (1906KB)(207) Cited By (8)
Abstract:

Severe liver disease during pregnancy is uncommon in clinical practice. The most common cause of liver disease during pregnancy is liver dysfunction,with an overall prevalence rate of approximately 3%. Liver disease during pregnancy is classified into the liver diseases directly caused by pregnancy ...

Association between sarcopenia and hepatic encephalopathy and advances in diagnosis and treatment
Li JianHong, Yao Jia, Yuan LiLi
2020, 36(6): 1412-1414. DOI: 10.3969/j.issn.1001-5256.2020.06.049
Abstract:

Sarcopenia is a component of malnutrition in patients with liver cirrhosis. Studies have shown that both sarcopenia and hepatic encephalopathy can reduce quality of life and increase the risk of adverse events,including death,in patients with liver cirrhosis. This article reviews the association bet...

Role of immune response and inflammatory injury in the pathogenesis of liver failure
Wang TingShuai, Wang Na, Zhang RongZhen, Wang MingGang, Huang ShaoDong, Ma YuZhen, Wu Cong, Mao DeWen
2020, 36(6): 1415-1419. DOI: 10.3969/j.issn.1001-5256.2020.06.050
Abstract(1558) PDF (1916KB)(240) Cited By (29)
Abstract:

Liver failure is a syndrome of severe liver diseases commonly seen in clinical practice,and it has a high mortality rate and thus becomes one of the critical diseases in internal medicine. Massive hepatocyte death and the extent of hepatocyte death exceeding the liver's regenerative capacity are con...

Management of patients with gallstones and acute cholecystitis during the epidemic of coronavirus disease 2019
Xu LuYao, Li ChangXu, Tang ChaoHui, Wang ShouQian, Wang YingChao
2020, 36(6): 1420-1422. DOI: 10.3969/j.issn.1001-5256.2020.06.051
Abstract(2101) PDF (1865KB)(145) Cited By (8)
Abstract:

At present,the epidemic of coronavirus disease 2019 is still serious,and the prevention and control of this epidemic is taken seriously throughout the country. As one of the most common acute abdominal diseases in hepatobiliary surgery,gallstones with acute cholecystitis has sudden onset and rapid p...

Clinical features and differential diagnosis of hemolytic jaundice
Zhang Jie, Zheng SuJun
2020, 36(6): 1423-1427. DOI: 10.3969/j.issn.1001-5256.2020.06.052
Abstract(3151) PDF (1959KB)(318) Cited By (14)
Abstract:

Hemolytic jaundice has various etiologies and clinical manifestations. Although some patients have hemolysis,they may have jaundice as the initial manifestation due to unobvious or mild anemia,and the disease may last for a long time with difficulties in treatment and can be misdiagnosed as unexplai...

Research advances in continuous blood purification in treatment of severe acute pancreatitis
Zhang YuYan, Zhang HaiRong, Zhang JingLi, Li Rui, Li RuoChang
2020, 36(6): 1428-1432. DOI: 10.3969/j.issn.1001-5256.2020.06.053
Abstract(1189) PDF (1907KB)(163) Cited By (20)
Abstract:

Severe acute pancreatitis( SAP) is a disease with dangerous course and poor prognosis,and although medical technology keeps improving over the years,the mortality rate of SAP remains high. As the latest achievement in the field of blood purification over the past 30 years,continuous blood purificati...